Astra's Pulmicort protects heart in COPD study (Reuters)


Reuters - AstraZeneca Plc's inhaled corticosteroid
drug Pulmicort may help reduce heart attacks and angina in
patients with "smoker's lung," or COPD, researchers said on
Monday.